Development of extended release coevaporates and coprecipitates of promethazine HCl with acrylic polymers: Formulation considerations

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 4, 2008, Pages 504-508

  Dahiya, Sunita ^a   Pathak, Kamla ^a   Sharma, Ruchi ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

Coevaporate; Coprecipitate; Eudragit RLPO; Eudragit RS100; Promethazine hydrochloride; Solid dispersion

Indexed keywords

CHLORIDE; DRUG VEHICLE; EUDRAGIT; EUDRAGIT RLPO; EUDRAGIT RS; EUDRAGIT RS100; PHOSPHATE BUFFERED SALINE; POLYACRYLIC ACID; POLYMER; PROMETHAZINE; UNCLASSIFIED DRUG; WATER;

ADSORPTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUTION; EVAPORATION; EXTENDED RELEASE SYSTEM; IN VITRO STUDY; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PH; POWDER X RAY DIFFRACTOMETRY; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; TABLET; TABLET COMPRESSION;

ACRYLATES; ANTI-ALLERGIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; POLYMETHACRYLIC ACIDS; PROMETHAZINE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 42049097210     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.504     Document Type: Article

References (20)

1. Yuasa H., Ozeki T., Kanaya Y., Oishi K., Oyake T., Chem. Pharm. Bull., 39, 465-467 (1991).
2. Pao-Chu W., Yaw-Bin H., Ming-Jun T., Yi-Hung T., Eur. J. Pharm. Sci., 19, 115-122 (2003).
3. Ozeki T., Yuasa H., Kanaya Y., Oishi K., Chem. Pharm. Bull., 43, 1574-1579 (1995).
4. Hasegawa A., Nakagawa H., Sugimoto I., Chem. Pharm. Bull., 33, 1615-1619 (1985).
5. Hasegawa A., Kawamura R., Nakagawa H., Sugimoto I., Chem. Pharm. Bull., 33, 3429-3435 (1985).
6. Hasegawa A., Kawamura R., Nakagawa H., Sugimoto I., Yakugaku Zasshi, 105, 586-592 (1985).
7. Hasegawa A., Kawamura R., Nakagawa H., Sugimoto I., Chem. Pharm. Bull., 34, 2183-2190 (1986).
8. Hasegawa A., Taguchi M., Suzuki R., Miyata T., Nakagawa H., Sugimoto I., Chem. Pharm. Bull., 36, 4941-4950 (1988).
9. Fujii M., Terai H., Mori T., Sawada Y., Matsumoto M., Chem. Pharm. Bull., 36, 2186-2192 (1988).
10. Fujii M., Harada K., Yamanobe K., Matsumoto M., Chem. Pharm. Bull., 36, 4908-4913 (1988).
11. Fujii M., Harada K., Matsumoto M., Chem. Pharm. Bull., 38, 2237-2241 (1990).
12. Fujii M., Harada K., Kakinuma K., Matsumoto M., Chem. Pharm. Bull., 39, 1886-1888 (1991).
13. Fujii M., Hasegawa J., Kitajima H., Matsumoto M., Chem. Pharm. Bull., 39, 3013-3017 (1991).
14. Tanaka N., Imai K., Okimoto K., Ueda S., Tokunaga Y., Ohike A., Ibuki R., Higaki K., Kimura T., J. Controlled Release, 108, 386-395 (2005).
15. Ammar H. O., Khalil R. M., Drug Dev. Ind. Pharm., 23, 1043-1054 (1997).
16. Mehta K. A., Kislalioglu M. S., Phuapradit W., Malick A. W., Shah N. H., Drug Dev. Ind. Pharm., 28, 275-285 (2002).
17. Pignatello R., Ferro M., Puglisi G., AAPS PharmSciTech., 3, 1-11 (2002).
18. Filippis P. D., Zingone G., Gibellini M., Rubessa F., Rupena P., Eur. J. Pharm. Sci., 3, 265-271 (1995).
19. Row R. C., Sheskey P. J., Owen S. C., "Handbook of Pharmaceutical Excipients," 5th ed., Pharmaceutical Press, London, 2006.
20. Banakar U. V., "Pharmaceutical Dissolution Testing," Vol. 49, Marcel Dekker Inc., New York, 1992.